Short Squeeze

Bullish Opportunity in Mylan Earnings

Short interest in pharma stock Mylan (MYL) increased 13% ahead of earnings, despite the company's strong fundamentals. Buy MYL to be on the right side of a short squeeze. More 

Shorting IPOs: An Especially Risky Bet

Many of the world's top investors short stocks, but shorting an IPO comes with extra risk. Here's what you need to know about the practice. More 

Herbalife: A $4 Billion, Ego-Soaked Cockfight

Joe Blow investors that try to play alongside Ackman or Icahn as they scrap over Herbalife will probably get their eyes pecked out. More 

Hedge Funds Battling Over Herbalife? Run!

Don't get caught between these titans as they do battle. On one side is Bill 'Pyramid Scheme' Ackman. On the other, Dan 'Buy It' Loeb. Oy. More 

Take Advantage of this Breakaway Stock

Another quarter of beating expectations and EPS growth will get the analysts upgrading their outlook on this stock, causing the “crowd” that follows an upgrade to buy the stock. More 

The Shorts Are Wrong on These 3 Stocks

Some bearish traders are getting a little too familiar with the "short" button -- and that means big squeeze possibilities for these stocks. More 

3 Stocks About to Be Squeezed Higher

These three stocks are technically set up to send the shorts fleeing for the exits, shooting their prices through the roof. More